PT Jayamas Medica Industri Tbk (ISX:OMED) Piotroski F-Score: 7 (As of Jun. 30, 2026) — Near Median


ISX:OMED PT Jayamas Medica Industri Tbk ISX:OMED
90 GF Score
Price Rp208.00
GF Value Rp236.50
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is PT Jayamas Medica Industri Tbk Piotroski F-Score?

PT Jayamas Medica Industri Tbk ISX:OMED +0.97% 90 Piotroski F-Score is 7 as of Jun. 30, 2026, which is at its 10-year median of 7.00. GuruFocus rates ISX:OMED with a GF Score™ of 90/100 and a GF Value™ of Rp236.50 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 806 Medical Devices & Instruments companies, PT Jayamas Medica Industri Tbk ranks better than 92.56% on this metric.

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

PT Jayamas Medica Industri Tbk has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for PT Jayamas Medica Industri Tbk's Piotroski F-Score or its related term are showing as below:

ISX:OMED' s Piotroski F-Score Range Over the Past 10 Years
Min: 5   Med: 7   Max: 8
Current: 7

During the past 7 years, the highest Piotroski F-Score of PT Jayamas Medica Industri Tbk was 8. The lowest was 5. And the median was 7.

PT Jayamas Medica Industri Tbk  (ISX:OMED) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


PT Jayamas Medica Industri Tbk Piotroski F-Score Related Terms


PT Jayamas Medica Industri Tbk Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for PT Jayamas Medica Industri Tbk's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Jayamas Medica Industri Tbk Piotroski F-Score Chart

PT Jayamas Medica Industri Tbk Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial N/A N/A 5.00 8.00 8.00

PT Jayamas Medica Industri Tbk Quarterly Data
Dec20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 7.00 6.00 8.00 7.00

ISX:OMED vs ISRG, BDX, MDLN: Piotroski F-Score Comparison

For the Medical Instruments & Supplies subindustry, PT Jayamas Medica Industri Tbk's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Jayamas Medica Industri Tbk Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PT Jayamas Medica Industri Tbk's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where PT Jayamas Medica Industri Tbk's Piotroski F-Score falls into.


ISX:OMED
90GF Score
PT Jayamas Medica Industri Tbk ISX:OMED
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 80967.619 + 100477.171 + 112740.269 + 98369.588 = Rp392,555 Mil.
Cash Flow from Operations was 61262.603 + 74599.091 + 155745.942 + 43273.284 = Rp334,881 Mil.
Revenue was 489530.669 + 544048.076 + 593922.691 + 572248.286 = Rp2,199,750 Mil.
Gross Profit was 165872.195 + 185517.096 + 219209.568 + 205929.494 = Rp776,528 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(2936534.223 + 2836860.821 + 3034968.589 + 3197846.92 + 3321884.497) / 5 = Rp3065619.01 Mil.
Total Assets at the begining of this year (Mar25) was Rp2,936,534 Mil.
Long-Term Debt & Capital Lease Obligation was Rp217,526 Mil.
Total Current Assets was Rp2,497,787 Mil.
Total Current Liabilities was Rp225,426 Mil.
Net Income was 80488.312 + 66977.634 + 110746.982 + 72763.697 = Rp330,977 Mil.

Revenue was 452259.622 + 484846.968 + 521327.012 + 436315.465 = Rp1,894,749 Mil.
Gross Profit was 153345.703 + 154948.834 + 177025.845 + 146896.784 = Rp632,217 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(2646510.813 + 2726580.554 + 2740441.955 + 2825331.332 + 2936534.223) / 5 = Rp2775079.7754 Mil.
Total Assets at the begining of last year (Mar24) was Rp2,646,511 Mil.
Long-Term Debt & Capital Lease Obligation was Rp17,323 Mil.
Total Current Assets was Rp2,321,624 Mil.
Total Current Liabilities was Rp328,655 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

PT Jayamas Medica Industri Tbk's current Net Income (TTM) was 392,555. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

PT Jayamas Medica Industri Tbk's current Cash Flow from Operations (TTM) was 334,881. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=392554.647/2936534.223
=0.13367958

ROA (Last Year)=Net Income/Total Assets (Mar24)
=330976.625/2646510.813
=0.1250615

PT Jayamas Medica Industri Tbk's return on assets of this year was 0.13367958. PT Jayamas Medica Industri Tbk's return on assets of last year was 0.1250615. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

PT Jayamas Medica Industri Tbk's current Net Income (TTM) was 392,555. PT Jayamas Medica Industri Tbk's current Cash Flow from Operations (TTM) was 334,881. ==> 334,881 <= 392,555 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=217526.055/3065619.01
=0.07095665

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=17323.464/2775079.7754
=0.00624251

PT Jayamas Medica Industri Tbk's gearing of this year was 0.07095665. PT Jayamas Medica Industri Tbk's gearing of last year was 0.00624251. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=2497787.467/225425.533
=11.08032189

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=2321623.85/328655.267
=7.06400926

PT Jayamas Medica Industri Tbk's current ratio of this year was 11.08032189. PT Jayamas Medica Industri Tbk's current ratio of last year was 7.06400926. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

PT Jayamas Medica Industri Tbk's number of shares in issue this year was 27008.12. PT Jayamas Medica Industri Tbk's number of shares in issue last year was 27058.85. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=776528.353/2199749.722
=0.35300759

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=632217.166/1894749.067
=0.33366802

PT Jayamas Medica Industri Tbk's gross margin of this year was 0.35300759. PT Jayamas Medica Industri Tbk's gross margin of last year was 0.33366802. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=2199749.722/2936534.223
=0.74909725

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=1894749.067/2646510.813
=0.71594231

PT Jayamas Medica Industri Tbk's asset turnover of this year was 0.74909725. PT Jayamas Medica Industri Tbk's asset turnover of last year was 0.71594231. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+0+0+1+1+1+1
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

PT Jayamas Medica Industri Tbk has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 7 mean?
PT Jayamas Medica Industri Tbk (ISX:OMED) has a Piotroski F-Score of 7 as of Jun. 30, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on PT Jayamas Medica Industri Tbk and its competitors. This is near median its historical median of 7.00. Over the past decade, PT Jayamas Medica Industri Tbk's Piotroski F-Score has ranged from 5.00 to 8.00. According to the industry distribution chart, PT Jayamas Medica Industri Tbk ranks #60 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 7.4%.
Is PT Jayamas Medica Industri Tbk's Piotroski F-Score too high?
PT Jayamas Medica Industri Tbk's current Piotroski F-Score of 7 is near median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 8.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. PT Jayamas Medica Industri Tbk's value of 7 is 40% above this industry median. Based on the distribution chart, PT Jayamas Medica Industri Tbk ranks #60 out of 806 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, PT Jayamas Medica Industri Tbk has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Jayamas Medica Industri Tbk's Piotroski F-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PT Jayamas Medica Industri Tbk ranks #60 out of 806 companies for Piotroski F-Score. This places PT Jayamas Medica Industri Tbk in the top 7% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. PT Jayamas Medica Industri Tbk's value of 7 is 40% above this benchmark. Historically, PT Jayamas Medica Industri Tbk's own Piotroski F-Score has ranged from 5.00 to 8.00 over the past decade. While the company's 10-year median is 7.00 vs. the industry median of 5.00, PT Jayamas Medica Industri Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Jayamas Medica Industri Tbk's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on PT Jayamas Medica Industri Tbk and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Jayamas Medica Industri Tbk's current Piotroski F-Score is 7, which is near median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Jayamas Medica Industri Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Jayamas Medica Industri Tbk (ISX:OMED) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp236.50, compared to a current price of Rp208.00 — trading 12.1% below its estimated fair value. The current Piotroski F-Score is 7, which is near median its 10-year median of 7.00 and 40% above the Medical Devices & Instruments industry median of 5.00. PT Jayamas Medica Industri Tbk's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For PT Jayamas Medica Industri Tbk (ISX:OMED), the current Piotroski F-Score is 7 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Jayamas Medica Industri Tbk (ISX:OMED) Overvalued in 2026?

Based on GuruFocus' analysis, PT Jayamas Medica Industri Tbk stock appears to be undervalued. The current stock price of Rp208.00 is trading 12.1% below its estimated GF Value™ of Rp236.50. GuruFocus considers PT Jayamas Medica Industri Tbk to be Modestly Undervalued.

Key valuation signals for ISX:OMED:

  • Piotroski F-Score: 7 (near median its 10-year median of 7.00)
  • GF Value™: Rp236.50 vs. price of Rp208.00 (12.1% below fair value)
  • GF Score™: 90/100 with 2 warning signs
  • Industry Position: 40% above the Medical Devices & Instruments median (#60 of 806)

No single metric tells the full story. See the ISX:OMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Jayamas Medica Industri Tbk Business Description

Address Sebelah Selatan Jalan By Pass RT 05 / RW 01, Sidomojo Village, Krian District, Sidoarjo, Jawa Timur, East Java, IDN, 61262
PT Jayamas Medica Industri Tbk is engaged in the business of manufacturing, wholesale and retail trade of medical devices. Its offerings include Disposable and Expendable Medical Supplies, Wound Care, Diagnostics and Equipment, Antiseptics and Dialysis, Biotechnology and Laboratory, Ambulatory and Rehabilitation Care The company has three segments: i) Manufacturing: This division is involved in the manufacturing of medical supplies and equipment, ii) Distribution: This division is involved with the large scale distribution of medical supplies and equipment at strategic locations, iii) Retail: This division is involved with the retail of medical supplies and equipment through Medicom stores and online platforms. The majority of the company's revenue is derived from the Distribution segment.
90GF Score

Get the complete analysis for ISX:OMED

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp208.00
Price
Rp236.50
GF Value